Section/topic |
# |
Checklist item |
Reported on page # |
RESULTS |
RESULTS |
RESULTS |
RESULTS |
Study selection |
17 |
Give numbers of studies screened,
assessed for eligibility, and included in the review, with reasons for
exclusions at each stage, ideally with a flow diagram. |
7, Figure 1,
Protocol |
Study characteristics |
18 |
For each study, present
characteristics for which data were extracted (e.g., study size, PICOS,
follow-up period) and provide the citations. |
12,13 and Table
2 |
Risk of bias within studies |
19 |
Present data on risk of
bias of each study and, if available, any outcome level assessment (see
item 12). |
NA |
Results of individual studies |
20 |
For all outcomes
considered (benefits or harms), present, for each study: (a) simple
summary data for each intervention group (b) effect estimates and
confidence intervals, ideally with a forest plot. |
Tables
3-5 |
Synthesis of results |
21 |
Present results of each
meta-analysis done, including confidence intervals and measures of
consistency. |
, Figures 2,3 |
Risk of bias across studies |
22 |
Present results of any
assessment of risk of bias across studies (see Item 15). |
NA |
Additional analysis |
23 |
Give results of additional
analyses, if done (e.g., sensitivity or subgroup analyses,
meta-regression [see Item 16]). |
Figures 2,3 |
DISCUSSION |
DISCUSSION |
DISCUSSION |
DISCUSSION |
Summary of evidence |
24 |
Summarize the main findings
including the strength of evidence for each main outcome; consider their
relevance to key groups (e.g., healthcare providers, users, and policy
makers). |
15-19 |
Limitations |
25 |
Discuss limitations at study and outcome
level (e.g., risk of bias), and at review-level (e.g., incomplete
retrieval of identified research, reporting bias). |
17 |
Conclusions |
26 |
Provide a general interpretation of the
results in the context of other evidence, and implications for future
research. |
19 |
FUNDING |
FUNDING |
FUNDING |
FUNDING |
Funding |
27 |
Describe sources of funding for the systematic
review and other support (e.g., supply of data); role of funders for the
systematic review. |
Acknowledgments |